Dermatology Review: February 2005

Dermatology Review, February 2005: This issue addresses recent advances in therapeutic options for a variety of skin diseases including atopic dermatitis, psoriasis, and rosacea. This issue brings you information on Dermatology Update, a leading forum for the sharing and learning about new drugs and exciting new therapeutic approaches in the field of dermatology, which held its 20th meeting October 14-16th, 2004. It combined workshops and plenary sessions led by Canadian dermatologists and international speakers. This issue of Focus on Dermatology brings you some exciting reports from those workshops and introduces you to two new drugs recently approved in Canada, Amevive and Cutivate. Clinical commentaries for this issue have been supplied by Dr. Lyn Guenther, Dr. Richard Thomas, Dr. Rod Kunynetz, Dr. Jerry Tan, and Dr. Ron Vender.

Topics covered are as follows:

• Long-Term Management of Atopic Dermatitis
• Psoriasis: Therapy Choices
• Developing an Integrated Acne Severity Assessment Tool (ASSET)
• Valacyclovir in The Treatment and Prevention of Herpes Infections
• Immune Response Modifiers - Clinical Advances
• AmeviveTM Product Information
• Cutivate® Product Information,
• Abstracts:
  
  • Current concepts and review of alefacept in the treatment of psoriasis
  • The kinetics of skin thinning induced by topical fluticasone propionate 0.05% cream in volunteer subjects
  • Comparison of cosmetic and physicochemical properties of six topical corticosteroid creams
  • Can Topical Corticosteroids Prevent the Relapse of Atopic Dermatitis?
  • Fluticasone propionate 0.05% cream once daily versus clobetasone butyrate 0.05% cream twice daily in children with atopic dermatitis
  • Remittive effects of intramuscular alefacept in psoriasis